Content about Teva Pharmaceutical Industries

October 10, 2011
FTC clears Teva-Cephalon acquisition deal

The Federal Trade Commission has given Teva Pharmaceutical Industries the green light to acquire Frazer, Pa.-based drug maker Cephalon, but with some restrictions, Teva said.

October 4, 2011
Taro adds new member to board

Taro Pharmaceutical Industries recently appointed a new member to its board, following the resignation of Hasmukh Shah.

October 4, 2011
Teva, The Medicines Co. settle suit over blood-thinning drug

The Medicines Co. and generic drug maker Teva Pharmaceutical Industries have reached a settlement that will allow Teva to start selling a generic version of one of MDCO's drugs by the end of the decade.

September 12, 2011
Biosimilar path to
 take form by patent cliff

It’s hard to disagree that generic drug companies have had a good run for the last several years. Branded drug companies developed a large number of drugs that proved highly effective at treating widespread medical conditions and became blockbusters, garnering billions of dollars in sales in the United States alone.

August 30, 2011
Federal court issues rulings in favor of Teva in MS drug case

A federal court has acted in favor of Teva Pharmaceutical Industries in the drug maker's patent infringement case against several generic drug companies seeking to market versions of its multiple sclerosis drug.

August 24, 2011
M&A: Multitudinous and ample

The final outcome of the battle between Israel’s Teva Pharmaceutical Industries and Canada’s Valeant Pharmaceuticals International to buy Cephalon serves as a good illustration of why it helps to have a plan B.


August 8, 2011
FDA accepts Teva approval application for BDP Nasal HFA

The Food and Drug Administration has accepted an approval application for a drug made by Teva Pharmaceutical Industries for treating allergies, Teva said.

July 29, 2011
Teva launches authorized generic of Seasonique

Teva Pharmaceuticals has launched an authorized generic version of a contraceptive made by Duramed Pharmaceuticals, Teva said.

July 15, 2011
Teva completes acquisition of Japanese generics company

Teva Pharmaceutical Industries has completed its acquisition of Japan’s third-largest generics company, Teva said.

July 15, 2011
Teva gets approval to buy Cephalon

Teva Pharmaceutical Industries got the go-ahead from Cephalon’s shareholders to acquire the Frazer, Pa.-based company in a deal worth $6.8 billion.

June 21, 2011
FDA approves first generic versions of Levaquin

The Food and Drug Administration Tuesday approved the first generic versions of an antibiotic designed to treat certain infections in people ages 18 years and older.

June 17, 2011
FDA rejects Teva's request to block Watson's generic Seasonique

A federal court has rejected Teva Pharmaceutical Industries’ efforts to prevent Watson from launching a generic version of one of its drugs, Watson said Friday.

June 15, 2011
Nasacort AQ generic enters market

Teva Pharmaceutical Industries has begun shipping a generic drug for allergies, partnering company Perrigo said Wednesday.

June 6, 2011
12 generic versions of Femara in market, FDA reports

The Food and Drug Administration has approved a dozen new generic versions of a drug used to treat breast cancer, the agency said Monday.

June 2, 2011
Teva's generic Aricept OKed by FDA

The Food and Drug Administration has approved a generic drug for Alzheimer’s disease made by Teva Pharmaceutical Industries.

May 26, 2011
Teva to market generic Combivir tablets

Teva Pharmaceutical Industries is set to market a generic version of an HIV treatment, the drug maker announced Thursday.

May 16, 2011
Teva to acquire Taiyo

Generic drug maker Teva Pharmaceutical Industries will acquire a privately owned manufacturer of generic drugs based in Japan, Teva said Monday.

May 9, 2011
Impax confirms patent challenge for generic Concerta

Alza Corp. is attempting to block Impax Labs from developing a generic version of Alza's attention deficit hyperactivity disorder treatment.

May 2, 2011
Teva comes up as front-runner to buy Cephalon

Cephalon has another suitor in the form of the world’s largest generic drug company.

April 13, 2011
FDA accepts regulatory application for Bio-T-Gel

The Food and Drug Administration has accepted a regulatory approval application for a topical treatment for low testosterone made by Teva Pharmaceuticals and BioSante Pharmaceuticals, BioSante said Wednesday.

April 12, 2011
Teva, Active Biotech: Laquinimod reduces relapses, disease progression in MS patients

An investigational drug made by Teva Pharmaceutical Industries and Active Biotech for multiple sclerosis reduced disease relapses and prevented the progression of disability, according to late-stage clinical trial results announced Monday.

March 29, 2011
Datamonitor: Global biosimilars market to reach nearly $4 billion by 2015

Any manufacturer that has the necessary resources and still is hesitating about whether to tap into biosimilars might want to go ahead and do it, if projections by British market analysis firm Datamonitor come true.

March 28, 2011
Teva launches chewable birth control pill

Teva Pharmaceuticals has launched a chewable birth control pill, the generic drug maker said Friday.

March 25, 2011
P&G, Teva deal: A complementary alignment

In the universe of business partnerships, a joint venture between Teva Pharmaceutical Industries and Procter & Gamble is like two galaxies coming together.

March 24, 2011
P&G, Teva enter partnership

Procter & Gamble and Teva Pharmaceutical Industries will bring their over-the-counter product lines and capabilities together in a deal they expect to be completed this fall.

© 2013 Drug Store News. All Rights Reserved.